NuGen Medical Devices Inc. NGMDF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.70K | 18.00K | 60.40K | 25.20K | 16.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.70K | 18.00K | 60.40K | 25.20K | 16.00K |
| Cost of Revenue | 1.70K | 7.90K | 36.50K | 9.80K | 6.40K |
| Gross Profit | 2.00K | 10.10K | 23.90K | 15.30K | 9.60K |
| SG&A Expenses | 719.20K | 764.50K | 736.30K | 882.60K | 608.80K |
| Depreciation & Amortization | 18.30K | 121.40K | 143.50K | -- | 118.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 739.10K | 893.80K | 916.40K | 892.40K | 733.60K |
| Operating Income | -735.50K | -875.80K | -856.00K | -867.20K | -717.60K |
| Income Before Tax | -721.30K | -1.18M | -3.69M | -1.36M | -1.68M |
| Income Tax Expenses | 300.00 | -- | 34.80K | -3.30K | 3.00K |
| Earnings from Continuing Operations | -721.60K | -1.18M | -3.73M | -1.36M | -1.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -721.60K | -1.18M | -3.73M | -1.36M | -1.68M |
| EBIT | -735.50K | -875.80K | -856.00K | -867.20K | -717.60K |
| EBITDA | -722.70K | -754.40K | -712.40K | -744.10K | -599.20K |
| EPS Basic | 0.00 | -0.01 | -0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 227.04M | 227.04M | 227.04M | 227.04M | 227.04M |
| Average Diluted Shares Outstanding | 227.04M | 227.04M | 227.04M | 227.04M | 227.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |